YYB101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for YYB101, covering 2022-11-14 to 2022-11-14. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients [Phase 1, Phase 2]